Skip to main content

Verlängerung der Aufwachphase durch das Zentral- Anti-Cholingergische Syndrom: ein Vergleich von Atropin und Glycopyrrolate

  • Conference paper
Zentraleuropäischer Anaesthesiekongreβ

Zusammenfassung

Anticholinergische Medikamente sind von jeher ein wesentlicher Faktor in der Praxis der Anästhesie. Die unbestreitbaren Vorteile — reduzierte Magen- und Speichelsekretionen, sowie ein gewisser Schutz gegen vagale Reflexe — haben bis vor kurzem nachteilige Nebenwirkungen überschattet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Longo VG (1966) Behavioral and electro-encephalographic effects of atropin and related compounds. PharmRev 18: 965–991

    CAS  Google Scholar 

  2. Ramamurthy S, Shaker MH, Winnie AP (1972) Glycopyrrolate as a substitute for atropine in neostigmine reversal of muscle relaxant drugs. Can Anaesth Soc J 19: 399–411

    Article  PubMed  CAS  Google Scholar 

  3. Bernards WC (1973) The central anticholinergic syndrome and its reversal with physostigmine. 20th Annual Anesthesiology Review Course, June 11–15,1973, San Antonio, Texas

    Google Scholar 

  4. Winnie AP, et al. (1975) Anticholinergic differences: A matter of safety. A scientific exhibit, presented at the 1975 ASA Annual Meeting, Chicago, Illinois

    Google Scholar 

  5. Greene LT (1971) Physostigmine treatment of anticholinergic drug depression in postoperative patients. Anesth and Analg (Cleve) 50: 222–226

    CAS  Google Scholar 

  6. Franko BV, Alphin RS, Ward JW, Lunceford CD (1962) Pharmacodynamic evaluation of glycopyrrolate in animals. Ann NY Acad Sci 99: 131–149

    Article  PubMed  CAS  Google Scholar 

  7. Proakis AG, Harris GB (1978) Comparative penetration of glycopyrrolate and atropine across the bloodbrain and placental barriers in anesthetized dogs. Anesthesiology 48: 339–344

    Article  PubMed  CAS  Google Scholar 

  8. Hoeprich PD (ed) (!977) Infectious Diseases, 2nd edn. Harper and Row, New York, pp 158, 897

    Google Scholar 

  9. Kane JG, et al. (1977) Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med 87: 309–311

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Brosch, F.R. (1981). Verlängerung der Aufwachphase durch das Zentral- Anti-Cholingergische Syndrom: ein Vergleich von Atropin und Glycopyrrolate. In: Haid, B.C., Mitterschiffthaler, G. (eds) Zentraleuropäischer Anaesthesiekongreβ. Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine, vol 139. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68188-2_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68188-2_34

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-10942-6

  • Online ISBN: 978-3-642-68188-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics